Cargando...
Sustained Remission of Severe Multicentric Castleman Disease Following Multiagent Chemotherapy and Tocilizumab Maintenance
Castleman disease is a rare lymphoproliferative disorder, which presents in a unicentric or multicentric fashion. Multicentric Castleman disease (MCD) is associated with significant systemic symptoms, in part related to the underlying role of interleukin-6 in disease pathogenesis. Treatment for MCD...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946294/ https://ncbi.nlm.nih.gov/pubmed/24019247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24761 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|